Literature DB >> 20084163

Challenges of incorporating pharmacogenomics into clinical practice.

Sharon Marsh1, Tibor van Rooij.   

Abstract

Year:  2009        PMID: 20084163      PMCID: PMC2806804     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


× No keyword cloud information.
  14 in total

1.  Pharmacogenomics--drug disposition, drug targets, and side effects.

Authors:  William E Evans; Howard L McLeod
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies.

Authors:  Howard L McLeod; Cristi R King; Sharon Marsh
Journal:  Clin Colorectal Cancer       Date:  2004-06       Impact factor: 4.481

3.  Drug pathways: moving beyond single gene pharmacogenetics.

Authors:  Howard L McLeod
Journal:  Pharmacogenomics       Date:  2004-03       Impact factor: 2.533

4.  Pharmacogenetics goes 3D.

Authors:  Howard L McLeod; Sharon Marsh
Journal:  Nat Genet       Date:  2005-08       Impact factor: 38.330

5.  Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing.

Authors:  Christine Patch; Jorge Sequeiros; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

6.  Personal genomics services: whose genomes?

Authors:  David Gurwitz; Yael Bregman-Eschet
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

Review 7.  Pharmacogenetics of colorectal cancer.

Authors:  Sharon Marsh
Journal:  Expert Opin Pharmacother       Date:  2005-12       Impact factor: 3.889

8.  The increasing role of pharmacogenetics in the treatment of gastrointestinal cancers.

Authors:  Suayib Yalçin
Journal:  Gastrointest Cancer Res       Date:  2009-09

9.  Irinotecan pharmacogenetics: influence of pharmacodynamic genes.

Authors:  Janelle M Hoskins; Eugenio Marcuello; Albert Altes; Sharon Marsh; Taylor Maxwell; Derek J Van Booven; Laia Paré; Robert Culverhouse; Howard L McLeod; Montserrat Baiget
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

Review 10.  Pharmacogenetics of irinotecan toxicity.

Authors:  Sharon Marsh; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2004-10       Impact factor: 2.533

View more
  1 in total

Review 1.  Irinotecan pharmacogenomics.

Authors:  Sharon Marsh; Janelle M Hoskins
Journal:  Pharmacogenomics       Date:  2010-07       Impact factor: 2.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.